Phase 3RecruitingNCT06630585
Tirzepatide as an adjunct to automated insulin delivery
Swiss randomized phase 3 study testing tirzepatide as an add-on to usual care in adults with type 1 diabetes using automated insulin delivery.
Primary endpoints
- Change in time-in-range at week 16
Results so far
No results posted yet.